# Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus

> **NCT00004643** · PHASE2 · COMPLETED · sponsor: **National Center for Research Resources (NCRR)** · enrollment: 10 (—)

## Conditions studied

- Lupus Erythematosus, Systemic

## Interventions

- **DRUG:** cytarabine

## Key facts

- **NCT ID:** NCT00004643
- **Lead sponsor:** National Center for Research Resources (NCRR)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 10 (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004643, "Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00004643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*